These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 28003743)

  • 1. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
    Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.
    Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tuberculosis in COPD.
    Yakar HI; Gunen H; Pehlivan E; Aydogan S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():323-329. PubMed ID: 28176901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory parameters predict poor outcome in COPD patients, category GOLD 2017 B.
    Brat K; Plutinsky M; Hejduk K; Svoboda M; Popelkova P; Zatloukal J; Volakova E; Fecaninova M; Heribanova L; Koblizek V
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1037-1052. PubMed ID: 29628761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative spirometry results as a determinant for long-term mortality after EVAR for AAA.
    Ohrlander T; Dencker M; Acosta S
    Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):43-7. PubMed ID: 22051733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining prognosis in acute exacerbation of COPD.
    Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis.
    Tanimura K; Sato S; Fuseya Y; Hasegawa K; Uemasu K; Sato A; Oguma T; Hirai T; Mishima M; Muro S
    Ann Am Thorac Soc; 2016 Mar; 13(3):334-41. PubMed ID: 26700501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative care and prognosis in COPD: a systematic review with a validation cohort.
    Almagro P; Yun S; Sangil A; Rodríguez-Carballeira M; Marine M; Landete P; Soler-Cataluña JJ; Soriano JB; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1721-1729. PubMed ID: 28652724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.
    Maekura R; Hiraga T; Miki K; Kitada S; Miki M; Yoshimura K; Yamamoto H; Kawabe T; Mori M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1787-800. PubMed ID: 26366071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Procalcitonin as a Biomarker for the Prediction of Bacterial Exacerbation and Mortality in Severe COPD Exacerbations Requiring Mechanical Ventilation.
    Ergan B; Şahin AA; Topeli A
    Respiration; 2016; 91(4):316-24. PubMed ID: 27081845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated index combined by dynamic hyperinflation and exercise capacity in the prediction of morbidity and mortality in COPD.
    Ozgür ES; Nayci SA; Özge C; Taşdelen B
    Respir Care; 2012 Sep; 57(9):1452-9. PubMed ID: 22348294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.
    Chen CZ; Ou CY; Hsu CH; Hsiue TR
    J Formos Med Assoc; 2015 Dec; 114(12):1258-66. PubMed ID: 25676673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
    Husebø GR; Grønseth R; Lerner L; Gyuris J; Hardie JA; Bakke PS; Eagan TM
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28298399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.
    Cardoso J; Coelho R; Rocha C; Coelho C; Semedo L; Bugalho Almeida A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1105-1113. PubMed ID: 29670346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.